复发性与持续性甲状腺癌的患者报告
基于乔治亚州和洛杉矶SEER登记处2014-2015年确诊的2632例分化型甲状腺癌患者调查(应答率63%),2454例报告当前疾病状态者中4.1%报告复发、5.8%报告持续性疾病。T3/T4分期和颈部淋巴结转移(N1)与复发及持续性疾病报告均相关,西班牙裔与复发报告相关。持续性疾病患者全球健康中位评分达到有意义变化标准。
要点
- 2454例分化型甲状腺癌患者中,4.1%报告复发,5.8%报告持续性疾病。
- T3/T4分期和N1均与复发及持续性疾病报告相关。
- 持续性疾病患者全球身体健康(T评分44.9)和心理健康(T评分43.5)达到有意义变化。
核心结论
- 患者报告是评估复发性和持续性疾病的一种合理方法。
- 报告持续性疾病患者的生活质量影响更为显著。
- 研究结果有助于为这些患者制定个性化治疗和长期随访。
研究设计与样本
- 2017年2月1日至2018年10月31日期间,调查乔治亚州和洛杉矶SEER癌症登记处2014-2015年确诊的分化型甲状腺癌合格患者(N=2632;应答率63%)。
- 纳入报告当前疾病状态的患者(n=2454),患者报告数据与登记数据链接。
- 采用多变量多项逻辑回归分析确定与复发性和持续性甲状腺癌相关的患者和肿瘤特征。
- 使用PROMIS-Global Health v1.2问卷评估生活质量;全球健康有意义变化定义为与匹配美国2000年人口普查的样本人群均值(T评分=50)相比最小差异为半个标准差或5分。
主要发现
- 2454例完成调查的患者中,95例(4.1%)报告复发,137例(5.8%)报告持续性疾病。
- 多项分析中,T3/T4分类与复发报告相关(调整RRR 1.99,95%CI 1.16-3.42),与持续性疾病报告相关(调整RRR 3.48,95%CI 1.96-6.20)。
- 颈部淋巴结受累(N1)与复发报告相关(调整RRR 2.03,95%CI 1.29-3.21),与持续性疾病报告相关(调整RRR 3.56,95%CI 2.41-5.24)。
- 西班牙裔与复发报告相关(调整RRR 1.99,95%CI 1.23-3.24)。
- 持续性疾病患者全球身体健康中位T评分44.9、全球心理健康中位T评分43.5,达到有意义变化标准;治愈或复发患者中位评分未达到有意义变化标准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Despite the excellent survival of most patients with differentiated thyroid cancer (DTC), recurrent and persistent disease remain major concerns for physicians and patients. However, studies on patient report of recurrent and persistent disease are lacking. Methods: Between February 1, 2017, and October 31, 2018, we surveyed eligible patients who were diagnosed with DTC between 2014 and 2015 from the Georgia and Los Angeles Surveillance, Epidemiology, and End Results cancer registries (N = 2632; response rate, 63%). Patients who reported current disease status were included in this study (n = 2454). Patient-reported data were linked to registry data. A multivariable, multinomial logistic regression analysis was conducted to determine patient and tumor characteristics associated with recurrent and persistent thyroid cancer. Quality of life was evaluated using the Patient-Reported Outcomes Measurement Information System-Global Health v1.2 questionnaire. Meaningful change in global health was defined as a minimal difference of a half standard deviation or 5 points compared with the mean (T score = 50) of a sample population matching the United States 2000 General Census. Results: Of the 2454 patients completing the survey, 95 (4.1%) reported recurrent disease and 137 (5.8%) reported persistent disease. In multinomial analyses, T3/T4 classification and cervical lymph node involvement (N1) were associated with both report of recurrent (adjusted relative risk ratio [RRR] 1.99, 95% confidence interval [CI 1.16-3.42]; adjusted RRR 2.03 [CI 1.29-3.21], respectively) and persistent disease (adjusted RRR 3.48 [CI 1.96-6.20]; adjusted RRR 3.56 [CI 2.41-5.24], respectively). Additionally, Hispanic ethnicity was associated with report of recurrent disease (adjusted RRR 1.99 [CI 1.23-3.24]). Regarding quality of life, the median scores in patients with persistent disease met criteria for meaningful change in global physical health (T-score = 44.9) and global mental health (T-score = 43.5) when compared with the general population norms. Median scores in patients with cured or recurrent disease did not meet criteria for meaningful change. Conclusions: Patient report is a reasonable method of assessing recurrent and persistent disease. Impact on quality of life is more marked for patients with reported persistent disease. Our findings will help personalize treatment and long-term follow-up in these patients.
引用
- Papaleontiou M, Evron JM, Esfandiari NH, et al. Patient Report of Recurrent and Persistent Thyroid Cancer. Thyroid. 2020. PMID: 32183609. doi:10.1089/thy.2019.0652
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。